# DIVALPROEX SODIUM
> **ANDA214462** · Abbreviated New Drug Application (Generic) · Sponsor: YICHANG HUMANWELL · Approved 2021-03-15
## Drug
- **FDA Application Number:** ANDA214462
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIVALPROEX SODIUM
- **Generic name:** Divalproex Sodium
- **Active ingredients:** DIVALPROEX SODIUM
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** YICHANG HUMANWELL
- **First approval:** 2021-03-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214462)
---
*MORVS · CC0 1.0*